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Abstract 
Introduction: This study investigated the antimicrobial resistance and clonality of Salmonella enterica serotype Kentucky in poultry and 
poultry sources in Nigeria, and compared the isolates with the clone of S. Kentucky STI98-X1 CIPR using (PFGE) and (MIC).  
Methodology: Fecal samples from chickens and poultry sources (litter, water, rodent and lizard fecal samples) were collected from  fourteen 
(14) poultry farms in 2007, 2010 and 2011 and were analyzed for S. Kentucky. 
Results and conclusions: Six percent of the samples were positive for S. Kentucky – all resistant to nalidixic acid and ciprofloxacin. The 
isolates are grouped within the PFGE cluster X1 of S. Kentucky STI98 CIPR, indicating the association to the emerging and widely spread 
CIPR S. Kentucky clone with poultry and poultry sources.  
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Introduction 
Salmonella enterica serotype Kentucky (S. 
Kentucky) has been closely associated with poultry 
since it was first isolated in 1937 from a chick in the 
United States of America (USA) [1].  
During the 1990s, a clone of ciprofloxacin-
resistant (CIPR) S. Kentucky (MIC > 0.06µg/mL 
according to EUCAST) of multilocus sequence type 
(MLST) ST198 containing pulsed-field gel 
electrophoresis (PFGE) pattern X1 emerged in Egypt, 
featuring high-level resistance to fluoroquinolones. 
Recently, the clone has spread to several countries, 
including sub-Saharan Africa, the Middle East, and 
Europe, causing infection in humans probably through 
contaminated imported foods or secondary 
contaminations [2].  
Since poultry has been identified as a potential 
major vehicle for infection by this clone [3], a One 
Health surveillance approach is needed to detect, 
understand, and monitor the spread and persistency of 
this multidrug-resistant clone.  
This study investigates the level of resistance and 
clonality of S. Kentucky in poultry and poultry sources 
over time in two geographical regions in Nigeria. 
Additionally, to compare the isolates with the clone of 
S. Kentucky STI98-X1 CIPR   based on PFGE and 
minimum inhibition concentration (MIC) 
determination.  
 
Methodology 
Fecal and environmental samples were collected 
from poultry houses in western (Ibadan) and 
northeastern (Maiduguri) regions of Nigeria in the 
years 2007 and 2010 to 2011, respectively. 
In Ibadan, a total of 641 samples from chickens 
were collected between March and May 2007 from 
nine different intensively managed farms, while in 
Maiduguri, five intensively managed poultry farms 
Raufu et al. – Salmonella Kentucky in poultry from Nigeria                            J Infect Dev Ctries 2014; 8(3):384-388. 
385 
were visited between November 2010 and February 
2011, and a total of 270 samples from chickens (feces) 
and poultry environment (litter, water, rodents, and 
lizards feces) were collected. Salmonella were 
presumptively identified using biochemical 
characterization according to the standard techniques 
recommended [4]. Full serotyping was carried out on 
all the presumptive isolates at the WHO reference 
laboratory in Thailand. MIC determination and PFGE 
were performed according to Hendriksen et al. [5]. 
The PFGE patterns were subsequently compared using 
Bionumeric software with the clone of S. Kentucky 
STI98-X1 CIPR [2]. The antimicrobials and resistance 
cut-off values (μg/mL) were: AMP, ampicillin (> 8); 
AUG, amoxicillin-clavulanic acid (≥ 32); APR, 
apramycin (> 32); XNL, ceftiofur (> 2); CHL, 
chloramphenicol (> 16); CIP, ciprofloxacin (0.064-1; 
> 1); COL, colistin (> 2); FFN, florfenicol (> 16); 
GEN, gentamicin (> 2); FOT, cefotaxime (> 0.5); 
NAL, nalidixic acid (> 16); NEO, neomycin (> 4); 
SPE, spectinomycin (> 64); STR, streptomycin (> 16); 
SMX, sulfamethoxazole (> 256); TET, tetracycline (> 
8); TMP, trimethoprim (> 2). The MIC test was 
carried out on the isolates using a commercially 
prepared, dehydrated panel (Sensititre; TREK 
Diagnostic Systems Ltd., East Grinstead, England). 
 
Results 
Out of an overall 911 samples analyzed, 55 (6%) 
were positive for S. Kentucky (44 and 11 isolates from 
Ibadan and Maiduguri respectively) . Forty-five of the 
isolates were from chicken fecal samples, while the 
remaining were distributed among samples from 
lizards (n = 3), water (n = 1), rodents (n = 5), and 
poultry house (litter ; n = 1), as shown in Figure 1. 
Generally, all the isolates from the two geographic 
regions were resistant to nalidixic acid and 
ciprofloxacin (MIC > 4 µg/mL); a full antibiogram is 
presented in Figure 1. In comparison to S. Kentucky 
from Maiduguri, the isolates from Ibadan exhibited the 
highest level of resistance, where isolate KS 13 from 
farm B conferred resistance to nine of all tested 
antimicrobials including ampicillin, ciprofloxacin, 
gentamicin, nalidixic acid, neomycin, spectomycin, 
streptomycin, sulfamethoxazole, and tetracycline. In 
addition, 28 isolates originating from nine different 
farms exhibited a similar resistance pattern, as KS 13 
(excluding neomycin) conferred resistance to eight 
antimicrobials (Figure 1). Eleven isolates from four 
farms in Ibadan and 11 isolates from five poultry 
farms in Maiduguri shared the same resistance profile: 
ciprofloxacin, gentamicin, nalidixic acid, neomycin, 
spectomycin, streptomycin, sulfamethoxazole, and 
tetracycline. 
None of the isolates were resistant to cefotaxime 
(FOT) and ceftiofur (XNL), indicating the absence of 
extended-spectrum cephalosporinases.  
 
The 55 isolates were separated into four overall 
PFGE clades which consisted of 36, 17, 1, and 1 
isolates, respectively (Figure 1). Among the two 
largest clades, seven clusters of indistinguishable 
PFGE patterns were observed. The largest cluster 
consisted of 23 isolates from Ibadan (2007) and all 
isolates from Maiduguri (2010-2011) except for one. 
The isolates from Ibadan were all from chickens 
sampled from nine farms, whereas the isolates from 
Maiduguri all were from poultry feces and poultry 
environment of five intensively managed farms. 
Additionally, all isolates represented different 
antimicrobial resistant profiles (Figure 
1). All the isolates were grouped within the PFGE 
cluster X1 of S. Kentucky STI98 CIPR (data not 
shown) [2]. 
 
Discussion 
This study investigated the presence of CIPR S. 
Kentucky isolates from poultry and poultry sources 
over time from two regions in Nigeria.  
We observed diversity based on PFGE, indicating 
the presence of several lineages in Nigeria. Despite the 
diversity, all samples still fell within the PFGE X1 
strain, affirming their long-term presence in the study 
region [2]. 
Beyond quinolone resistance, additional resistance 
to streptomycin, spectinomycin, gentamicin, 
sulfamethoxazole, and tetracycline were observed in 
some CIPR S. Kentucky isolates, which points to the 
presence of SGI (9, 10, 11); further studies are 
required to confirm this speculation. The lack of 
effective policy to regulate the use of 
fluoroquinolones, including ciprofloxacin, 
enrofloxacin, and ofloxacin, in chicken production in 
Nigeria (unpublished data) may have contributed to 
the dissemination of multidrug-resistant non-typhoidal 
Salmonella; rapid spread has also been observed in 
Southeast Asia [2]. The emergence and spread of 
clinically significant clonal groups of Salmonella 
appear to occur on a regular basis [9]. 
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  Figure 1. Dendrogram showing the genotypic relatedness of the Salmonella enterica serovar Kentucky isolates from Nigeria based on 
XbaI PFGE fingerprints 
Black squares represent the isolates classified as resistant, Abbreviations: AMP, Ampicillin; AUG, amoxicillin + clavulanic acid; APR, apramycin; FOT, 
cefotaxime; XNL, ceftiofur; CHL, chloramphenicol; CIP, ciprofloxacin; COL, colistin; FFN, florfenicol; GEN, gentamicin; NAL, nalidixic acid; NEO, 
neomycin; SPE, spectinomycin; STR,streptomycin; SMX, sulfamethoxazole; TET, tetracycline; TMP, trimethoprim. 
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This study documented a significant contamination of 
poultry with multidrug-resistant S. Kentucky, which 
reaffirmed the initial speculation of the existence of a 
prevailing circulating poultry-associated STI98-X1 
CIPR S. Kentucky in Africa, including Nigeria [2]. We 
speculate that one or more traits must be present in this 
serovar that underlie its success as colonizer of 
chickens; perhaps among these traits are those 
facilitating specific host–bacterial interactions and 
those that survive in modern poultry farm 
environments [10,11]. Further studies will be needed 
to confirm these hypotheses. 
The extent of the emergence of the ST198-X1 
CIPR S. Kentucky clone in the poultry sector in 
different regions of Africa remains to be determined, 
but this preliminary investigation has revealed that 
poultry in Nigeria, where the industry uses indigenous 
domestic fowl, are largely contaminated with a single 
strain as defined by PFGE. This did not corroborate 
the hypothesis that the dissemination of a common 
contaminated poultry lineage throughout Africa might 
be responsible for the dissemination of this clone. 
More likely, it is contaminated food ingredients, 
including human food [12], that serve as a portal of 
entry into the agriculture production systems [13]. 
Practices such as the intensive (deep litter) and 
semi-intensive systems practised by most poultry 
establishments coupled with the unhygienic 
environment and poor management practices probably 
contribute to the spread and emergence of the clone 
and its widespread distribution and cross 
contamination of litter, reptiles, water, rodents, and 
lizards [14,15].  
 
Conclusion 
Our study revealed the association of CIPR S. 
Kentucky with poultry and the poultry environment. 
The lack of effective policy to control the use of 
antimicrobials in poultry in Nigeria may have 
contributed to its spread. 
It is recommended that the authorities in Nigeria 
establish a National Salmonella Surveillance Program 
for effective long-term national and international joint 
integrated public health surveillance with surveillance 
of food animal populations for prompt identification 
and control of the epidemic non-typhoid Salmonella, 
including ST198-X1 CIPR S. Kentucky clone; these 
would greatly increase the likelihood of early 
detection before the bacteria become widely 
disseminated. The data generated will enable policy 
makers to legislate on antimicrobial use in agriculture 
and clinical settings and the sub-therapeutic use of 
antimicrobials to promote growth and feeding 
efficiency in animals; this would lead to a reduction in 
antimicrobial resistance. 
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